Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients. (Q48955354)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

Antonio Iannelli

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Francesco Martini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Anne Sophie Schneck

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Bijan Ghavami

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Guillaume Baudin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Obesity Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1761-1765

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686653%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Noninvasive assessment of hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Visceral adipose tissue area is an independent risk factor for hepatic steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Factors determining conversion from laparoscopic to open Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Preoperative low energy diet diminishes liver size

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Change in liver size and fat content after treatment with Optifast very low calorie diet

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Autonomic function, omega-3, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Non-alcoholic fatty liver disease: further expression of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0942-Y

21 January 2018

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity and nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mediterranean diet in healthy lifestyle and prevention of stroke.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of a low-carbohydrate diet on the nonalcoholic fatty liver in morbidly obese patients before bariatric surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic steatosis: correlations of body mass index, CT fat measurements, and liver density with biopsy results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of nonalcoholic fatty liver disease in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48955354&oldid=2209884259"